Mitoxantrone hydrochloride and Posaconazole drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mitoxantrone hydrochloride (mitoxantrone hydrochloride) and Posaconazole (posaconazole). Common drug interactions include bone neoplasm among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Mitoxantrone hydrochloride and Posaconazole. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Mitoxantrone hydrochloride?

Mitoxantrone hydrochloride has active ingredients of mitoxantrone hydrochloride. eHealthMe is studying from 1,060 Mitoxantrone hydrochloride users. Check the latest studies of Mitoxantrone hydrochloride.

What is Posaconazole?

Posaconazole has active ingredients of posaconazole. eHealthMe is studying from 9,475 Posaconazole users. Check the latest studies of Posaconazole.

On Jul, 07, 2026

38 people who take Mitoxantrone hydrochloride and Posaconazole together, and have interactions are studied.

Mitoxantrone hydrochloride and Posaconazole drug interactions.

What are the common drug interactions of Mitoxantrone Hydrochloride and Posaconazole, by gender? *:

female:

Bone neoplasm (tumour of bone)
Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
Device related infection
Disease progression
Drug ineffective
Graft versus host disease in lung (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the lung)
Stenotrophomonas infection
Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
Escherichia sepsis (bacterial infection by escherichia coli)
Mucormycosis (a rare infection caused by organisms that belong to a group of fungi called mucoromycotina)

male:

Drug ineffective
Drug resistance (reduction in effectiveness of a drug)
Encephalitis (inflammation of the brain)
Fungaemia (fungi circulate in the blood)
Hydrocephalus (water on the brain)
Hypokalaemia (low potassium)
Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
Lipase increased
Respiratory failure (inadequate gas exchange by the respiratory system)
Dry skin

What are the common drug interactions of Mitoxantrone Hydrochloride and Posaconazole, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Cerebral hypoperfusion (a condition in which the brain doesn't get enough blood)
Encephalitis (inflammation of the brain)
Hydrocephalus (water on the brain)
Hypokalaemia (low potassium)
Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
Lipase increased
Respiratory failure (inadequate gas exchange by the respiratory system)

10-19:

Rash maculo-papular (red area on the skin that is covered with small confluent bumps)

20-29:

n/a

30-39:

Bone neoplasm (tumour of bone)
Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
Device related infection
Disease progression
Drug ineffective
Graft versus host disease in lung (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the lung)
Stenotrophomonas infection

40-49:

n/a

50-59:

Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
Escherichia sepsis (bacterial infection by escherichia coli)
Mucormycosis (a rare infection caused by organisms that belong to a group of fungi called mucoromycotina)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)

60+:

Drug ineffective
Drug resistance (reduction in effectiveness of a drug)
Dry skin
Erythema (redness of the skin)
Eye swelling
Face oedema (swelling of face)
Inflammatory marker increased
Localised infection (infection at the single location)
Photosensitivity reaction
Rash

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 28 people, 73.68%
Bone Marrow Conditioning Regimen: 16 people, 42.11%
Obliterative Bronchiolitis (bronchiolar inflammation): 5 people, 13.16%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 5 people, 13.16%
Pain: 4 people, 10.53%
Nausea And Vomiting: 3 people, 7.89%
Skin Blushing/flushing (a sudden reddening of the face, neck): 2 people, 5.26%
Psychotic Disorder: 2 people, 5.26%
Nausea (feeling of having an urge to vomit): 2 people, 5.26%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Mitoxantrone hydrochloride and Posaconazole?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously